Back Samols, E, Marks, V (23 Feb 1963) 'Insulin assay in insulinomas', British Medical Journal , 1/5329, 507-10
Stricter inspections will continue in coming weeks
We are strongly encouraging patients to double check their insurance to see if their coverage has changed and then have a conversation with their health care professional around the possibility of switching to a branded obesity medication
Those with stable, quiescent disease may be reasonable candidates, provided they understand the importance of monitoring for symptom changes and maintaining close communication with both their gastroenterologist and prescribing physician
Medications like Ozempic closely mimic this hormone, helping patients feel fuller longer, reducing appetite, and ultimately contributing to significant weight loss
If you have any questions in the meantime, don't hesitate to reach out